Literature DB >> 23709709

Temporal trends in acute stroke management.

Dawn Kleindorfer1, Felipe de los Rios La Rosa, Pooja Khatri, Brett Kissela, Jason Mackey, Opeolu Adeoye.   

Abstract

Entities:  

Keywords:  epidemiology; stroke; thrombolysis

Mesh：

Substances：

Year:  2013        PMID： 23709709      PMCID： PMC4586151          DOI： 10.1161/STROKEAHA.113.001457

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  10 in total

1.  Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.

Authors:  Opeolu Adeoye; Richard Hornung; Pooja Khatri; Dawn Kleindorfer
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

2.  Emergency department arrival times after acute ischemic stroke during the 1990s.

Authors:  Dawn O Kleindorfer; Joseph P Broderick; Jane Khoury; Matthew L Flaherty; Daniel Woo; Kathleen Alwell; Charles J Moomaw; Arthur Pancioli; Edward Jauch; Rosie Miller; Brett M Kissela
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

3.  US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke.

Authors:  Dawn Kleindorfer; Yingying Xu; Charles J Moomaw; Pooja Khatri; Opeolu Adeoye; Richard Hornung
Journal:  Stroke       Date:  2009-10-01       Impact factor: 7.914

4.  Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.

Authors:  Felipe de Los Ríos la Rosa; Jane Khoury; Brett M Kissela; Matthew L Flaherty; Kathleen Alwell; Charles J Moomaw; Pooja Khatri; Opeolu Adeoye; Daniel Woo; Simona Ferioli; Dawn O Kleindorfer
Journal:  Stroke       Date:  2012-03-22       Impact factor: 7.914

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

7.  Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.

Authors:  Dawn Kleindorfer; Brett Kissela; Alex Schneider; Daniel Woo; Jane Khoury; Rosemary Miller; Kathleen Alwell; James Gebel; Jerzy Szaflarski; Arthur Pancioli; Edward Jauch; Charles Moomaw; Rakesh Shukla; Joseph P Broderick
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914

8.  National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.

Authors:  Dawn Kleindorfer; Christopher J Lindsell; Lawrence Brass; Walter Koroshetz; Joseph P Broderick
Journal:  Stroke       Date:  2008-01-31       Impact factor: 7.914

9.  Population-based analysis of the impact of expanding the time window for acute stroke treatment.

Authors:  Jennifer Juhl Majersik; Melinda A Smith; Darin B Zahuranec; Brisa N Sánchez; Lewis B Morgenstern
Journal:  Stroke       Date:  2007-10-25       Impact factor: 7.914

10.  Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

Authors:  Gregory J Del Zoppo; Jeffrey L Saver; Edward C Jauch; Harold P Adams
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914
  10 in total
  18 in total

1.  Erratum: Contraindications to intravenous rtPA for acute stroke: A critical reappraisal.

Authors: 
Journal:  Neurol Clin Pract       Date:  2013-10

2.  Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.

Authors:  Andrea Tampieri; Eugenio Giovannini; Anna Maria Rusconi; Lorenzo Cristoni; Daniela Bendanti; Patrizia Cenni; Tiziano Lenzi
Journal:  Intern Emerg Med       Date:  2014-11-28       Impact factor: 3.397

3.  Emerging temporal trends in tissue plasminogen activator use: Results from the BASIC project.

Authors:  Joseph S Domino; Jonggyu Baek; William J Meurer; Nelda Garcia; Lewis B Morgenstern; Morgan Campbell; Lynda D Lisabeth
Journal:  Neurology       Date:  2016-10-21       Impact factor: 9.910

4.  Inability to consent does not diminish the desirability of stroke thrombolysis.

Authors:  Winston Chiong; Anthony S Kim; Ivy A Huang; Nita A Farahany; S Andrew Josephson
Journal:  Ann Neurol       Date:  2014-07-09       Impact factor: 10.422

5.  Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke.

Authors:  Daniel Torrente; Enming Joseph Su; Linda Fredriksson; Mark Warnock; David Bushart; Kris M Mann; Cory D Emal; Daniel A Lawrence
Journal:  Transl Stroke Res       Date:  2022-02-04       Impact factor: 6.800

Review 6.  tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.

Authors:  Linda Fredriksson; Daniel A Lawrence; Robert L Medcalf
Journal:  Semin Thromb Hemost       Date:  2016-09-27       Impact factor: 4.180

7.  Stroke Hospital Characteristics in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study.

Authors:  Maria A Ciliberti-Vargas; Hannah Gardener; Kefeng Wang; Chuanhui Dong; Li Yi; Jose G Romano; Mary Robichaux; Salina P Waddy; Ulises Nobo; Sandra Diaz-Acosta; Tatjana Rundek; Michael F Waters; Ralph L Sacco
Journal:  South Med J       Date:  2017-07       Impact factor: 0.954

Review 8.  A novel mechanism of neuroprotection: Blood glutamate grabber.

Authors:  José Castillo; María Isabel Loza; David Mirelman; José Brea; Miguel Blanco; Tomás Sobrino; Francisco Campos
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

9.  Emergency Care of Patients with Acute Ischemic Stroke in the Kaiser Permanente Southern California Integrated Health System.

Authors:  Kori Sauser-Zachrison; Ernest Shen; Zahra Ajani; William P Neil; Navdeep Sangha; Michael K Gould; Adam L Sharp
Journal:  Perm J       Date:  2016-03-25

10.  Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection.

Authors:  Roy Cohen; James P Lata; Yurim Lee; Jean C Cruz Hernández; Nozomi Nishimura; Chris B Schaffer; Chinatsu Mukai; Jacquelyn L Nelson; Sharon A Brangman; Yash Agrawal; Alexander J Travis
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.